Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Vicarious Surgical Inc. WT RBOT-WT NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
36/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Vicarious Surgical Inc. WT (RBOT-WT) is a Medical - Devices company in the Healthcare sector, currently trading at $0.01. It has a SharesGrow Score of 33/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Net income is $50M (loss), growing at -482.2%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $8M against $10M equity (Debt-to-Equity (D/E) ratio 0.79, moderate). Current ratio is 2.97 (strong liquidity). Debt-to-assets is 39.8%. Total assets: $20M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 75/100 (Pass), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

RBOT-WT SharesGrow Score Overview

36/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 75/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — RBOT-WT

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
RBOT-WT: +0%/yr revenue is, -482.2%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
RBOT-WT: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
75/100
Balance sheet RBOT-WT: Debt-to-Equity (D/E) ratio 0.79 (moderate), Current ratio is 2.97 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
RBOT-WT: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0082-0.0213
Volume138.82K
Avg Volume (30D)861.67K
Market Cap$14.16M
Beta (1Y)1.52
Share Statistics
EPS (TTM)-8.45
Shares Outstanding$5.94M
Employees123
CEOAdam David Sachs
Financial Highlights & Ratios
Gross Profit$-1.43M
EBITDA$-49.54M
Net Income$-50.18M
Operating Income$-50.97M
Total Cash$9.79M
Total Debt$7.79M
Net Debt$5.22M
Total Assets$19.58M
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS92561V1171

Price Chart

Track all markets on TradingView
RBOT-WT
Vicarious Surgical Inc. WT ↗  ·  NYSE
Healthcare • Medical - Devices
0.01 52WK RANGE 0.02

People Also View

DNA-WT
DNA-WT
Ginkgo Bioworks Holdings, Inc. WT
$0.27
-2.76%
 QSIAW
QSIAW
Quantum-Si incorporated
$0.11
+5.00%
 RBOT
RBOT
Vicarious Surgical Inc.
$0.70
-5.57%
 INDIW
INDIW
indie Semiconductor, Inc.
$1.26
-3.08%
 SHPW-WT
SHPW-WT
Shapeways Holdings, Inc.
$0.02
+0.56%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message